| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/19/2005 | CN1185354C Method for analyzing plant extract |
| 01/19/2005 | CN1185350C DNA comprising rice anther-specific gene and transgenic plant transformed therewith |
| 01/19/2005 | CN1185349C Process for constructing temp.-tolerant plants |
| 01/19/2005 | CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof |
| 01/19/2005 | CN1185347C Thermostable enzyme promoting fidelity of thermostable DNA polymerase for improvement of nucleic acid synthesis and amplification in vitro |
| 01/19/2005 | CN1185346C Oligonucleotide for detecting salmonellae |
| 01/19/2005 | CN1185345C Gene for coding tomato-ethylene reaction bindin/AP2DNA binding domain transcription factor |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185342C Oligonucleotide of coding human parathyroid hormone and its high effective expression method |
| 01/19/2005 | CN1185341C Method for preparing medicine using silkworm expressed human beta interferon |
| 01/19/2005 | CN1185340C Method for producing medicine using silkworm expressed human alpha2b interferon |
| 01/19/2005 | CN1185261C Interleukin -2/granulocyte-macrophage colony stimulating factor fusion protein |
| 01/19/2005 | CN1185256C Rice tiller control gene MOC1 and its application |
| 01/19/2005 | CN1185248C Ribosomal deactivated protein gene |
| 01/19/2005 | CN1185012C DNA vaccine pVFS of SARS virus |
| 01/19/2005 | CN1185011C DNA vaccine pVPS of SARS virus |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/19/2005 | CN1184878C Plants, seeds and oils having elevated total monounsaturated fatty acid content |
| 01/18/2005 | US6844486 Nac1—a plant gene encoding a transcription factor involved in cotyledon and lateral root development |
| 01/18/2005 | US6844485 Nucleic acids encoding a phytochelatin synthase and uses thereof |
| 01/18/2005 | US6844484 Arabidopsis BIO2 gene promoter |
| 01/18/2005 | US6844483 Screening activity of hypotensive agents; obtain mammal, administer hypotensive agent, monitor adjustments in hypertension |
| 01/18/2005 | US6844433 Nucleic acid labeling compounds |
| 01/18/2005 | US6844432 Hybrid detector; amplification |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/18/2005 | US6844324 Having membrane fusion component comprising antennapedia binding domain motif or functional equivalent; lysine and aspartic acid attachment of each component; can accomodate large DNA molecules |
| 01/18/2005 | US6844323 Polypeptide-calcitonin 11 and the polynucleotide encoding it |
| 01/18/2005 | US6844193 Detecting ligand for fibroblast growth factor binding protein; obtain nucleotide sequence libraries, obtain cells, transform cell with nucleotide sequences, monitor kinase activity, amplified activity indicates presence of ligand |
| 01/18/2005 | US6844192 Preparing preferential viral vectors; provide packaging cell, transfect with nucleotide sequences coding viral vector, culture transfected cells, recover packaged vector |
| 01/18/2005 | US6844191 Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein |
| 01/18/2005 | US6844190 Binding protein for use in the treatment of pain, schizophrenia, depression, obsessive compulsive disorder, anxiety, migraines and pain |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6844171 Oligomerization of hepatitis delta antigen |
| 01/18/2005 | US6844169 Producing transgenic eschericheria as bioreator for controlling expression of heterologous proteins within trytpphan operon |
| 01/18/2005 | US6844165 For diagnosis, drug discovery; both parallel and muliplex analyte processing capabilities; retentate chromatography is a combinatorial method to provide high information resolution of analytes in complex mixtures |
| 01/18/2005 | US6844164 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 01/18/2005 | US6844157 Detection of microorganism in sample; obtain sample containing microorganism, extract nucleotide sequence, incubate with probe, detect hybridization pattern and compare to control containing microorganism |
| 01/18/2005 | US6844155 Monitoring polymerase chain reaction sample for impurities; amplfy nucleotide sequences, screen sample for impurities |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6844152 Detection of microsatellite instability and its use in diagnosis of tumors |
| 01/18/2005 | US6844148 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 01/18/2005 | US6844011 Methods for inhibiting rejection of transplanted tissue |
| 01/18/2005 | US6843999 Streptococcal ABC transporter protein |
| 01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | US6843988 Synferon |
| 01/18/2005 | US6843987 Contacting pure or recombinant mammalian (interleukin)IL- 1 delta or IL-L1 epsilon with a receptor comprising the IL-1R6 receptor subunit; or mammalian IL-1 delta or IL-1 epsilon with a receptor to form complex |
| 01/18/2005 | CA2188660C Detection of mutation by resolvase cleavage |
| 01/18/2005 | CA2169603C Retrovirus from the hiv group and its use |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/13/2005 | WO2005003778A2 A method for identifying a synthetic molecule having affinity towards a target |
| 01/13/2005 | WO2005003769A1 Bio-chip |
| 01/13/2005 | WO2005003720A2 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior |
| 01/13/2005 | WO2005003395A1 Method for amplifying and detecting nucleic acids in microfluidic devices under continuous and non-continuous flow conditions |
| 01/13/2005 | WO2005003389A2 In vitro amplification of dna |
| 01/13/2005 | WO2005003380A1 Methods for detecting aneuploidy using microparticle multiplex detection |
| 01/13/2005 | WO2005003375A2 Methods of amplifying and sequencing nucleic acids |
| 01/13/2005 | WO2005003371A2 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | WO2005003364A2 Stable integrands |
| 01/13/2005 | WO2005003363A1 Recombinant dna viruses comprising a dna that is complementary to an rna virus replicon, and applications thereof |
| 01/13/2005 | WO2005003362A2 Methods to confer herbicide resistance |
| 01/13/2005 | WO2005003361A1 A method for obtaining improved fertility restorer lines for transgenic male sterile crop plants and a dna construct for use in said method |
| 01/13/2005 | WO2005003360A1 Novel rubisco promoters and uses thereof |
| 01/13/2005 | WO2005003359A1 Method and system of constructing transgenic organism |
| 01/13/2005 | WO2005003358A1 Inhibition of calcitriol mediated cyp24 induction screening for compounds therefore and uses thereof |
| 01/13/2005 | WO2005003357A1 Feedback resistant acetohydroxy acid synthethase mutants |
| 01/13/2005 | WO2005003356A1 ENDO-β-(1→6)-GALACTANASE |
| 01/13/2005 | WO2005003355A1 Method for the identification of fungicidal compounds based on mevalonate kinases as fungi |
| 01/13/2005 | WO2005003354A2 Methods and means for regulating gene expression |
| 01/13/2005 | WO2005003353A1 Genetically modified brucella cells and pharmaceutical composition containing these cells |
| 01/13/2005 | WO2005003352A1 Method of judging responsivenesses to taxans |
| 01/13/2005 | WO2005003351A1 Differential expression of nucleic acid molecules |
| 01/13/2005 | WO2005003350A2 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER’S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/13/2005 | WO2005003348A2 Disease resistant transgenic non-human animals |
| 01/13/2005 | WO2005003347A2 Dna-based aptamers for human cathepsin g |
| 01/13/2005 | WO2005003346A1 Purification device for ribonucleic acid in large volumes, and method |
| 01/13/2005 | WO2005003345A2 Look-through mutagenesis |
| 01/13/2005 | WO2005003344A1 Method for the isolation of expressed sequence tags in plants |
| 01/13/2005 | WO2005003343A1 Novel microorganism, maltose phosphorylase, trehalose phosphorylase, and processes for producing these |
| 01/13/2005 | WO2005003342A1 Method of preparing transgenic organism with use of methylation and system therefor |
| 01/13/2005 | WO2005003341A1 Cell-free protein synthesizing method by continuous energy supply system using intracellular component |
| 01/13/2005 | WO2005003339A1 Food additive comprising pseudomonas non-maltogenic exoamylase variants |
| 01/13/2005 | WO2005003338A1 Nod-factor perception |
| 01/13/2005 | WO2005003322A2 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 01/13/2005 | WO2005003315A2 Compositions and methods for peptide-assisted transfection |
| 01/13/2005 | WO2005003313A2 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | WO2005003312A2 Elevation of oil levels in plants |
| 01/13/2005 | WO2005003310A2 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast |
| 01/13/2005 | WO2005003293A2 pRNA CHIMERA |
| 01/13/2005 | WO2005003289A2 Ap1 amine oxidase variants |
| 01/13/2005 | WO2005003174A1 BINDING MEMBER TOWARDS PNEUMOCOCCUS SURFACE ADHESIN A PROTEIN (PsaA) |
| 01/13/2005 | WO2005003165A2 Cytokine variant polypeptides |
| 01/13/2005 | WO2005003164A2 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 01/13/2005 | WO2005003162A2 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | WO2005003159A1 Complement depletion using recombinant human c3-derivatives |